摘要
目的探讨异丙托溴铵联合沐舒坦雾化吸入对开胸术后肺部并发症的预防效果研究。方法将115例拟行开胸手术患者随机分为2组,2组术前均予常规护理,对照组在此基础上予以沐舒坦雾化吸入,观察组在常规护理基础上联合异丙托溴铵和沐舒坦雾化吸入。结果观察组疗效显著优于对照组(P<0.05),观察组肺部感染率显著低于对照组(P<0.05)。结论异丙托溴铵联合沐舒坦雾化吸入对开胸术后预防肺部并发症效果显著,并有助于患者恢复。
Objective To investigate the ipratropium bromide combined with Ambroxol Aerosol Inhalation on preventive effect of pulmonary complications after thoracotomy. Method 115 patients undergoing thoracic operation were randomly divided into 2 groups, 2 groups were given routine nursing before operation, the control group on the basis of Mucosolvan atomization inhalation, the observation group in the conventional nursing combined with ipratropium bromide and atomization inhalation of ambroxol. Results the curative effect of therapeutic group was signiifcantly better than the control group (P<0.05); lung infection in the observation group was significantly lower than that of the control group (P<0.05). Conclusion ipratropium bromide and Mucosolvan aerosol inhalation signiifcantly on the prevention of pulmonary complications after thoracotomy and effect, will help the patient restore.
出处
《中国生化药物杂志》
CAS
北大核心
2014年第1期93-94,共2页
Chinese Journal of Biochemical Pharmaceutics
关键词
开胸术
异丙托溴铵
沐舒坦雾化吸入
肺部并发症
thoracotomy
ipratropium bromide
ambroxol aerosol inhalation
pulmonary complications